WuXi XDC Cayman Inc. (HKG:2268)
Hong Kong
· Delayed Price · Currency is HKD 58.55
-0.70 (-1.18%)
Apr 29, 2026, 4:08 PM HKT
WuXi XDC Cayman Employees
WuXi XDC Cayman had 2,662 employees as of December 31, 2025. The number of employees increased by 621 or 30.43% compared to the previous year.
Employees
2,662
Change (1Y)
621
Growth (1Y)
30.43%
Revenue / Employee
2.48M HKD
Profits / Employee
618.90K HKD
Market Cap
73.79B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2,662 | 621 | 30.43% |
| Dec 31, 2024 | 2,041 | 863 | 73.26% |
| Dec 31, 2023 | 1,178 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Guanze Medical Information Industry (Holding) | 58 |
| Adicon Holdings | 5,071 |
| Mega Genomics | 203 |
| Kindstar Globalgene Technology | 3,100 |
| China Biotech Services Holdings | 135 |
| Biosino Bio-Technology and Science Incorporation | 471 |
| Yunkang Group | 1,146 |
| King International Investment | 13 |
WuXi XDC Cayman News
- 22 days ago - Akari Therapeutics Announces Strategic Partnership With WuXi XDC - Nasdaq
- 5 weeks ago - WuXi XDC Cayman Earnings Call Transcript: H2 2025 - Transcripts
- 6 weeks ago - US reshoring drive casts shadow over China’s contract drug makers: analyst - South China Morning Post